# FDA Inspection 1076386 - Astellas Pharma Inc. - December 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/a7ea92a0-d1df-42dc-9013-79b27fde200b
Source feed: FDA_Inspections

> FDA Inspection 1076386 for Astellas Pharma Inc. on December 13, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1076386
- Company Name: Astellas Pharma Inc.
- Inspection Date: 2018-12-13
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1274304 - 2025-06-06](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/94872362-abf5-4e6b-9d98-eeae80d432f2)
- [FDA Inspection 1274304 - 2025-06-06](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/a0c6d68f-877a-4b4d-bcc2-fdcf4c30a727)
- [FDA Inspection 886634 - 2014-06-27](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/607e23b3-386b-4f56-b934-1263f6ffe731)
- [FDA Inspection 633570 - 2009-10-15](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/05b3849d-f185-4df1-b1b1-4ad80e215f1c)

Company: https://www.keypedia.com/companies/astellas-pharma-inc/23dd5b22-f65a-44d8-ba32-8de91558f67f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c